APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Stabilizers

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RNA Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchRNA Stabilizers Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Stabilizers Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal RNA Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Stabilizers Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA Stabilizers Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global RNA Stabilizers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNA Stabilizers include Yeasen, YaJi Biological, NCM Biotech, Thermo Fisher Scientific, Vazyme, Merck, Maokangbio, Beyotime and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global RNA Stabilizers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RNA Stabilizers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RNA Stabilizers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RNA Stabilizers market size, projected growth trends, production technologies, key applications, and end-use industries.

RNA Stabilizers Segment by Company

Yeasen

YaJi Biological

NCM Biotech

Thermo Fisher Scientific

Vazyme

Merck

Maokangbio

Beyotime

Zymo Research

Takara Bio

SRL

Omega Bio-Tek

NZYtech

New England Biolabs

Genetix Biotech Asia

G-Biosciences

Dutscher

BioEntist

RNA Stabilizers Segment by Type

Solid Phase Stabilizers

Spray or Coating-Based Stabilizers

Solution-Based Stabilizers

RNA Stabilizers Segment by Application

Molecular Biology

Genomics

RNA Stabilizers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Stabilizers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the RNA Stabilizers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RNA Stabilizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of RNA Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of RNA Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. RNA Stabilizers Industry Trends Table 2. RNA Stabilizers Industry Drivers Table 3. RNA Stabilizers Industry Opportunities and Challenges Table 4. RNA Stabilizers Industry Restraints Table 5. Global RNA Stabilizers Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global RNA Stabilizers Revenue Market Share by Manufacturers (2021-2026) Table 7. Global RNA Stabilizers Sales by Manufacturers (L) & (2021-2026) Table 8. Global RNA Stabilizers Sales Market Share by Manufacturers Table 9. Global RNA Stabilizers Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global RNA Stabilizers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global RNA Stabilizers Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global RNA Stabilizers Manufacturers, Product Type & Application Table 13. Global RNA Stabilizers Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global RNA Stabilizers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Solid Phase Stabilizers Table 17. Major Manufacturers of Spray or Coating-Based Stabilizers Table 18. Major Manufacturers of Solution-Based Stabilizers Table 19. Global RNA Stabilizers Sales by Type 2021 VS 2025 VS 2032 (L) Table 20. Global RNA Stabilizers Sales by Type (2021-2026) & (L) Table 21. Global RNA Stabilizers Sales by Type (2027-2032) & (L) Table 22. Global RNA Stabilizers Sales Market Share by Type (2021-2026) Table 23. Global RNA Stabilizers Sales Market Share by Type (2027-2032) Table 24. Global RNA Stabilizers Revenue by Type 2021 VS 2025 VS 2032 (L) Table 25. Global RNA Stabilizers Revenue by Type (2021-2026) & (L) Table 26. Global RNA Stabilizers Revenue by Type (2027-2032) & (L) Table 27. Global RNA Stabilizers Revenue Market Share by Type (2021-2026) Table 28. Global RNA Stabilizers Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Molecular Biology Table 30. Major Manufacturers of Genomics Table 31. Global RNA Stabilizers Sales by Application 2021 VS 2025 VS 2032 (L) Table 32. Global RNA Stabilizers Sales by Application (2021-2026) & (L) Table 33. Global RNA Stabilizers Sales by Application (2027-2032) & (L) Table 34. Global RNA Stabilizers Sales Market Share by Application (2021-2026) Table 35. Global RNA Stabilizers Sales Market Share by Application (2027-2032) Table 36. Global RNA Stabilizers Revenue by Application 2021 VS 2025 VS 2032 (L) Table 37. Global RNA Stabilizers Revenue by Application (2021-2026) & (L) Table 38. Global RNA Stabilizers Revenue by Application (2027-2032) & (L) Table 39. Global RNA Stabilizers Revenue Market Share by Application (2021-2026) Table 40. Global RNA Stabilizers Revenue Market Share by Application (2027-2032) Table 41. Global RNA Stabilizers Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global RNA Stabilizers Sales by Region (2021-2026) & (L) Table 43. Global RNA Stabilizers Sales Market Share by Region (2021-2026) Table 44. Global RNA Stabilizers Sales Forecasted by Region (2027-2032) & (L) Table 45. Global RNA Stabilizers Sales Forecasted Market Share by Region (2027-2032) Table 46. North America RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 47. North America RNA Stabilizers Sales by Country (2021-2026) & (L) Table 48. North America RNA Stabilizers Sales by Country (2027-2032) & (L) Table 49. Europe RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 50. Europe RNA Stabilizers Sales by Country (2021-2026) & (L) Table 51. Europe RNA Stabilizers Sales by Country (2027-2032) & (L) Table 52. Asia Pacific RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 53. Asia Pacific RNA Stabilizers Sales by Country (2021-2026) & (L) Table 54. Asia Pacific RNA Stabilizers Sales by Country (2027-2032) & (L) Table 55. South America, Middle East and Africa RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 56. South America, Middle East and Africa RNA Stabilizers Sales by Country (2021-2026) & (L) Table 57. South America, Middle East and Africa RNA Stabilizers Sales by Country (2027-2032) & (L) Table 58. Global RNA Stabilizers Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global RNA Stabilizers Revenue by Region (2021-2026) & (US$ Million) Table 60. Global RNA Stabilizers Revenue by Region (2027-2032) & (US$ Million) Table 61. Global RNA Stabilizers Revenue Market Share by Region (2021-2026) Table 62. Global RNA Stabilizers Revenue Market Share by Region (2027-2032) Table 63. Yeasen Company Information Table 64. Yeasen Business Overview Table 65. Yeasen RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yeasen RNA Stabilizers Product Portfolio Table 67. Yeasen Recent Development Table 68. YaJi Biological Company Information Table 69. YaJi Biological Business Overview Table 70. YaJi Biological RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. YaJi Biological RNA Stabilizers Product Portfolio Table 72. YaJi Biological Recent Development Table 73. NCM Biotech Company Information Table 74. NCM Biotech Business Overview Table 75. NCM Biotech RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. NCM Biotech RNA Stabilizers Product Portfolio Table 77. NCM Biotech Recent Development Table 78. Thermo Fisher Scientific Company Information Table 79. Thermo Fisher Scientific Business Overview Table 80. Thermo Fisher Scientific RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Thermo Fisher Scientific RNA Stabilizers Product Portfolio Table 82. Thermo Fisher Scientific Recent Development Table 83. Vazyme Company Information Table 84. Vazyme Business Overview Table 85. Vazyme RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vazyme RNA Stabilizers Product Portfolio Table 87. Vazyme Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merck RNA Stabilizers Product Portfolio Table 92. Merck Recent Development Table 93. Maokangbio Company Information Table 94. Maokangbio Business Overview Table 95. Maokangbio RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Maokangbio RNA Stabilizers Product Portfolio Table 97. Maokangbio Recent Development Table 98. Beyotime Company Information Table 99. Beyotime Business Overview Table 100. Beyotime RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Beyotime RNA Stabilizers Product Portfolio Table 102. Beyotime Recent Development Table 103. Zymo Research Company Information Table 104. Zymo Research Business Overview Table 105. Zymo Research RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zymo Research RNA Stabilizers Product Portfolio Table 107. Zymo Research Recent Development Table 108. Takara Bio Company Information Table 109. Takara Bio Business Overview Table 110. Takara Bio RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Takara Bio RNA Stabilizers Product Portfolio Table 112. Takara Bio Recent Development Table 113. SRL Company Information Table 114. SRL Business Overview Table 115. SRL RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. SRL RNA Stabilizers Product Portfolio Table 117. SRL Recent Development Table 118. Omega Bio-Tek Company Information Table 119. Omega Bio-Tek Business Overview Table 120. Omega Bio-Tek RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Omega Bio-Tek RNA Stabilizers Product Portfolio Table 122. Omega Bio-Tek Recent Development Table 123. NZYtech Company Information Table 124. NZYtech Business Overview Table 125. NZYtech RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. NZYtech RNA Stabilizers Product Portfolio Table 127. NZYtech Recent Development Table 128. New England Biolabs Company Information Table 129. New England Biolabs Business Overview Table 130. New England Biolabs RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. New England Biolabs RNA Stabilizers Product Portfolio Table 132. New England Biolabs Recent Development Table 133. Genetix Biotech Asia Company Information Table 134. Genetix Biotech Asia Business Overview Table 135. Genetix Biotech Asia RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Genetix Biotech Asia RNA Stabilizers Product Portfolio Table 137. Genetix Biotech Asia Recent Development Table 138. G-Biosciences Company Information Table 139. G-Biosciences Business Overview Table 140. G-Biosciences RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. G-Biosciences RNA Stabilizers Product Portfolio Table 142. G-Biosciences Recent Development Table 143. Dutscher Company Information Table 144. Dutscher Business Overview Table 145. Dutscher RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Dutscher RNA Stabilizers Product Portfolio Table 147. Dutscher Recent Development Table 148. BioEntist Company Information Table 149. BioEntist Business Overview Table 150. BioEntist RNA Stabilizers Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. BioEntist RNA Stabilizers Product Portfolio Table 152. BioEntist Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. RNA Stabilizers Distributors List Table 156. RNA Stabilizers Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. RNA Stabilizers Product Image Figure 2. Global RNA Stabilizers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RNA Stabilizers Market Size (2021-2032) & (US$ Million) Figure 4. Global RNA Stabilizers Sales (2021-2032) & (L) Figure 5. Global RNA Stabilizers Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Solid Phase Stabilizers Image Figure 9. Spray or Coating-Based Stabilizers Image Figure 10. Solution-Based Stabilizers Image Figure 11. Global RNA Stabilizers Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global RNA Stabilizers Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global RNA Stabilizers Sales Market Share by Type (2021-2032) Figure 14. Global RNA Stabilizers Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 15. Global RNA Stabilizers Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global RNA Stabilizers Revenue Market Share by Type (2021-2032) Figure 17. Molecular Biology Image Figure 18. Genomics Image Figure 19. Global RNA Stabilizers Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global RNA Stabilizers Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global RNA Stabilizers Sales Market Share by Application (2021-2032) Figure 22. Global RNA Stabilizers Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global RNA Stabilizers Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global RNA Stabilizers Revenue Market Share by Application (2021-2032) Figure 25. North America RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 26. North America RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 27. U.S. RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 28. Canada RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 29. Mexico RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 31. Europe RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 32. Germany RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 33. France RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 34. U.K. RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 35. Italy RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 36. Netherlands RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 38. Asia Pacific RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 39. China RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 40. Japan RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 41. South Korea RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 42. Southeast Asia RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 43. India RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 44. Australia RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 46. South America, Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 47. Brazil RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 48. South Africa RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 49. Saudi Arabia RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 50. Turkey RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 51. Argentina RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 52. UAE RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 53. Egypt RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 54. Chile RNA Stabilizers Sales and Growth Rate (2021-2032) & (L) Figure 55. Global RNA Stabilizers Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global RNA Stabilizers Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America RNA Stabilizers Revenue (2021-2032) & (US$ Million) Figure 58. North America RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe RNA Stabilizers Revenue (2021-2032) & (US$ Million) Figure 60. Europe RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific RNA Stabilizers Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa RNA Stabilizers Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. RNA Stabilizers Value Chain Figure 66. Manufacturing Cost Structure Figure 67. RNA Stabilizers Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Phase Stabilizers
  • Spray or Coating-Based Stabilizers
  • Solution-Based Stabilizers
Applications
  • Molecular Biology
  • Genomics
Companies covered
  • Yeasen
  • YaJi Biological
  • NCM Biotech
  • Thermo Fisher Scientific
  • Vazyme
  • Merck
  • Maokangbio
  • Beyotime
  • Zymo Research
  • Takara Bio
  • SRL
  • Omega Bio-Tek
  • NZYtech
  • New England Biolabs
  • Genetix Biotech Asia
  • G-Biosciences
  • Dutscher
  • BioEntist

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global RNA Stabilizers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global RNA Stabilizers Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global RNA Stabilizers Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global RNA Stabilizers Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global RNA Stabilizers Market Dynamics
  1. 2.1 RNA Stabilizers Industry Trends
  2. 2.2 RNA Stabilizers Industry Drivers
  3. 2.3 RNA Stabilizers Industry Opportunities and Challenges
  4. 2.4 RNA Stabilizers Industry Restraints
3 RNA Stabilizers Market by Manufacturers
  1. 3.1 Global RNA Stabilizers Revenue by Manufacturers (2021-2026)
  2. 3.2 Global RNA Stabilizers Sales by Manufacturers (2021-2026)
  3. 3.3 Global RNA Stabilizers Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global RNA Stabilizers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RNA Stabilizers Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global RNA Stabilizers Manufacturers, Product Type & Application
  7. 3.7 Global RNA Stabilizers Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RNA Stabilizers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RNA Stabilizers Tier 1, Tier 2, and Tier 3
4 RNA Stabilizers Market by Type
  1. 4.1 RNA Stabilizers Type Introduction
  2. 4.1.1 Solid Phase Stabilizers
  3. 4.1.2 Spray or Coating-Based Stabilizers
  4. 4.1.3 Solution-Based Stabilizers
  5. 4.2 Global RNA Stabilizers Sales by Type
  6. 4.2.1 Global RNA Stabilizers Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global RNA Stabilizers Sales by Type (2021-2032)
  8. 4.2.3 Global RNA Stabilizers Sales Market Share by Type (2021-2032)
  9. 4.3 Global RNA Stabilizers Revenue by Type
  10. 4.3.1 Global RNA Stabilizers Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global RNA Stabilizers Revenue by Type (2021-2032)
  12. 4.3.3 Global RNA Stabilizers Revenue Market Share by Type (2021-2032)
5 RNA Stabilizers Market by Application
  1. 5.1 RNA Stabilizers Application Introduction
  2. 5.1.1 Molecular Biology
  3. 5.1.2 Genomics
  4. 5.2 Global RNA Stabilizers Sales by Application
  5. 5.2.1 Global RNA Stabilizers Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global RNA Stabilizers Sales by Application (2021-2032)
  7. 5.2.3 Global RNA Stabilizers Sales Market Share by Application (2021-2032)
  8. 5.3 Global RNA Stabilizers Revenue by Application
  9. 5.3.1 Global RNA Stabilizers Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global RNA Stabilizers Revenue by Application (2021-2032)
  11. 5.3.3 Global RNA Stabilizers Revenue Market Share by Application (2021-2032)
6 Global RNA Stabilizers Sales by Region
  1. 6.1 Global RNA Stabilizers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RNA Stabilizers Sales by Region (2021-2032)
  3. 6.2.1 Global RNA Stabilizers Sales by Region (2021-2026)
  4. 6.2.2 Global RNA Stabilizers Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America RNA Stabilizers Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe RNA Stabilizers Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific RNA Stabilizers Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa RNA Stabilizers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa RNA Stabilizers Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global RNA Stabilizers Revenue by Region
  1. 7.1 Global RNA Stabilizers Revenue by Region
  2. 7.1.1 Global RNA Stabilizers Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global RNA Stabilizers Revenue by Region (2021-2026)
  4. 7.1.3 Global RNA Stabilizers Revenue by Region (2027-2032)
  5. 7.1.4 Global RNA Stabilizers Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America RNA Stabilizers Revenue (2021-2032)
  8. 7.2.2 North America RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe RNA Stabilizers Revenue (2021-2032)
  11. 7.3.2 Europe RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific RNA Stabilizers Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa RNA Stabilizers Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa RNA Stabilizers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yeasen
  2. 8.1.1 Yeasen Company Information
  3. 8.1.2 Yeasen Business Overview
  4. 8.1.3 Yeasen RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yeasen RNA Stabilizers Product Portfolio
  6. 8.1.5 Yeasen Recent Developments
  7. 8.2 YaJi Biological
  8. 8.2.1 YaJi Biological Company Information
  9. 8.2.2 YaJi Biological Business Overview
  10. 8.2.3 YaJi Biological RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 YaJi Biological RNA Stabilizers Product Portfolio
  12. 8.2.5 YaJi Biological Recent Developments
  13. 8.3 NCM Biotech
  14. 8.3.1 NCM Biotech Company Information
  15. 8.3.2 NCM Biotech Business Overview
  16. 8.3.3 NCM Biotech RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NCM Biotech RNA Stabilizers Product Portfolio
  18. 8.3.5 NCM Biotech Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 Vazyme
  26. 8.5.1 Vazyme Company Information
  27. 8.5.2 Vazyme Business Overview
  28. 8.5.3 Vazyme RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vazyme RNA Stabilizers Product Portfolio
  30. 8.5.5 Vazyme Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck RNA Stabilizers Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Maokangbio
  38. 8.7.1 Maokangbio Company Information
  39. 8.7.2 Maokangbio Business Overview
  40. 8.7.3 Maokangbio RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Maokangbio RNA Stabilizers Product Portfolio
  42. 8.7.5 Maokangbio Recent Developments
  43. 8.8 Beyotime
  44. 8.8.1 Beyotime Company Information
  45. 8.8.2 Beyotime Business Overview
  46. 8.8.3 Beyotime RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beyotime RNA Stabilizers Product Portfolio
  48. 8.8.5 Beyotime Recent Developments
  49. 8.9 Zymo Research
  50. 8.9.1 Zymo Research Company Information
  51. 8.9.2 Zymo Research Business Overview
  52. 8.9.3 Zymo Research RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zymo Research RNA Stabilizers Product Portfolio
  54. 8.9.5 Zymo Research Recent Developments
  55. 8.10 Takara Bio
  56. 8.10.1 Takara Bio Company Information
  57. 8.10.2 Takara Bio Business Overview
  58. 8.10.3 Takara Bio RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Takara Bio RNA Stabilizers Product Portfolio
  60. 8.10.5 Takara Bio Recent Developments
  61. 8.11 SRL
  62. 8.11.1 SRL Company Information
  63. 8.11.2 SRL Business Overview
  64. 8.11.3 SRL RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SRL RNA Stabilizers Product Portfolio
  66. 8.11.5 SRL Recent Developments
  67. 8.12 Omega Bio-Tek
  68. 8.12.1 Omega Bio-Tek Company Information
  69. 8.12.2 Omega Bio-Tek Business Overview
  70. 8.12.3 Omega Bio-Tek RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
  72. 8.12.5 Omega Bio-Tek Recent Developments
  73. 8.13 NZYtech
  74. 8.13.1 NZYtech Company Information
  75. 8.13.2 NZYtech Business Overview
  76. 8.13.3 NZYtech RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NZYtech RNA Stabilizers Product Portfolio
  78. 8.13.5 NZYtech Recent Developments
  79. 8.14 New England Biolabs
  80. 8.14.1 New England Biolabs Company Information
  81. 8.14.2 New England Biolabs Business Overview
  82. 8.14.3 New England Biolabs RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 New England Biolabs RNA Stabilizers Product Portfolio
  84. 8.14.5 New England Biolabs Recent Developments
  85. 8.15 Genetix Biotech Asia
  86. 8.15.1 Genetix Biotech Asia Company Information
  87. 8.15.2 Genetix Biotech Asia Business Overview
  88. 8.15.3 Genetix Biotech Asia RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
  90. 8.15.5 Genetix Biotech Asia Recent Developments
  91. 8.16 G-Biosciences
  92. 8.16.1 G-Biosciences Company Information
  93. 8.16.2 G-Biosciences Business Overview
  94. 8.16.3 G-Biosciences RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 G-Biosciences RNA Stabilizers Product Portfolio
  96. 8.16.5 G-Biosciences Recent Developments
  97. 8.17 Dutscher
  98. 8.17.1 Dutscher Company Information
  99. 8.17.2 Dutscher Business Overview
  100. 8.17.3 Dutscher RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dutscher RNA Stabilizers Product Portfolio
  102. 8.17.5 Dutscher Recent Developments
  103. 8.18 BioEntist
  104. 8.18.1 BioEntist Company Information
  105. 8.18.2 BioEntist Business Overview
  106. 8.18.3 BioEntist RNA Stabilizers Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BioEntist RNA Stabilizers Product Portfolio
  108. 8.18.5 BioEntist Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 RNA Stabilizers Value Chain Analysis
  2. 9.1.1 RNA Stabilizers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 RNA Stabilizers Production Mode & Process
  6. 9.2 RNA Stabilizers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 RNA Stabilizers Distributors
  9. 9.2.3 RNA Stabilizers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst